BACKGROUND: In this study, we assessed whether the white-coat effect (difference between office and daytime blood pressure (BP)) is associated with nondipping (absence of BP decrease at night). METHODS: Data were available in 371 individuals of African descent from 74 families selected from a population-based hypertension register in the Seychelles Islands and in 295 Caucasian individuals randomly selected from a population-based study in Switzerland. We used standard multiple linear regression in the Swiss data and generalized estimating equations to account for familial correlations in the Seychelles data. RESULTS: The prevalence of systolic and diastolic nondipping (<10% nocturnal BP decrease) and white-coat hypertension (WCH) was respectively 51, 46, and 4% in blacks and 33, 37, and 7% in whites. When white coat effect and nocturnal dipping were taken as continuous variables (mm Hg), systolic (SBP) and diastolic BP (DBP) dipping were associated inversely and independently with white-coat effect (P < 0.05) in both populations. Analogously, the difference between office and daytime heart rate was inversely associated with the difference between daytime and night-time heart rate in the two populations. These results did not change after adjustment for potential confounders. CONCLUSIONS: The white-coat effect is associated with BP nondipping. The similar associations between office-daytime values and daytime-night-time values for both BP and heart rate suggest that the sympathetic nervous system might play a role. Our findings also further stress the interest, for clinicians, of assessing the presence of a white-coat effect as a means to further identify patients at increased cardiovascular risk and guide treatment accordingly.
BACKGROUND: In this study, we assessed whether the white-coat effect (difference between office and daytime blood pressure (BP)) is associated with nondipping (absence of BP decrease at night). METHODS: Data were available in 371 individuals of African descent from 74 families selected from a population-based hypertension register in the Seychelles Islands and in 295 Caucasian individuals randomly selected from a population-based study in Switzerland. We used standard multiple linear regression in the Swiss data and generalized estimating equations to account for familial correlations in the Seychelles data. RESULTS: The prevalence of systolic and diastolic nondipping (<10% nocturnal BP decrease) and white-coat hypertension (WCH) was respectively 51, 46, and 4% in blacks and 33, 37, and 7% in whites. When white coat effect and nocturnal dipping were taken as continuous variables (mm Hg), systolic (SBP) and diastolic BP (DBP) dipping were associated inversely and independently with white-coat effect (P < 0.05) in both populations. Analogously, the difference between office and daytime heart rate was inversely associated with the difference between daytime and night-time heart rate in the two populations. These results did not change after adjustment for potential confounders. CONCLUSIONS: The white-coat effect is associated with BP nondipping. The similar associations between office-daytime values and daytime-night-time values for both BP and heart rate suggest that the sympathetic nervous system might play a role. Our findings also further stress the interest, for clinicians, of assessing the presence of a white-coat effect as a means to further identify patients at increased cardiovascular risk and guide treatment accordingly.
Authors: Sandosh Padmanabhan; Olle Melander; Toby Johnson; Anna Maria Di Blasio; Wai K Lee; Davide Gentilini; Claire E Hastie; Cristina Menni; Maria Cristina Monti; Christian Delles; Stewart Laing; Barbara Corso; Gerjan Navis; Arjan J Kwakernaak; Pim van der Harst; Murielle Bochud; Marc Maillard; Michel Burnier; Thomas Hedner; Sverre Kjeldsen; Björn Wahlstrand; Marketa Sjögren; Cristiano Fava; Martina Montagnana; Elisa Danese; Ole Torffvit; Bo Hedblad; Harold Snieder; John M C Connell; Morris Brown; Nilesh J Samani; Martin Farrall; Giancarlo Cesana; Giuseppe Mancia; Stefano Signorini; Guido Grassi; Susana Eyheramendy; H Erich Wichmann; Maris Laan; David P Strachan; Peter Sever; Denis Colm Shields; Alice Stanton; Peter Vollenweider; Alexander Teumer; Henry Völzke; Rainer Rettig; Christopher Newton-Cheh; Pankaj Arora; Feng Zhang; Nicole Soranzo; Timothy D Spector; Gavin Lucas; Sekar Kathiresan; David S Siscovick; Jian'an Luan; Ruth J F Loos; Nicholas J Wareham; Brenda W Penninx; Ilja M Nolte; Martin McBride; William H Miller; Stuart A Nicklin; Andrew H Baker; Delyth Graham; Robert A McDonald; Jill P Pell; Naveed Sattar; Paul Welsh; Patricia Munroe; Mark J Caulfield; Alberto Zanchetti; Anna F Dominiczak Journal: PLoS Genet Date: 2010-10-28 Impact factor: 5.917
Authors: Jean Jacques Noubiap; Jobert Richie Nansseu; Jan René Nkeck; Ulrich Flore Nyaga; Jean Joel Bigna Journal: J Clin Hypertens (Greenwich) Date: 2018-07-09 Impact factor: 3.738
Authors: Prossie Merab Ingabire; Dike B Ojji; Brian Rayner; Elijah Ogola; Albertino Damasceno; Erika Jones; Anastase Dzudie; Okechukwu S Ogah; Neil Poulter; Mahmoud U Sani; Felix Ayub Barasa; Grace Shedul; John Mukisa; David Mukunya; Bonnie Wandera; Charles Batte; James Kayima; Shahiemah Pandie; Charles Kiiza Mondo Journal: BMC Cardiovasc Disord Date: 2021-05-22 Impact factor: 2.298
Authors: Heba Alwan; Menno Pruijm; Belen Ponte; Daniel Ackermann; Idris Guessous; Georg Ehret; Jan A Staessen; Kei Asayama; Philippe Vuistiner; Sandrine Estoppey Younes; Fred Paccaud; Grégoire Wuerzner; Antoinette Pechere-Bertschi; Markus Mohaupt; Bruno Vogt; Pierre-Yves Martin; Michel Burnier; Murielle Bochud Journal: PLoS One Date: 2014-03-24 Impact factor: 3.240